Eylward Susan has filed 4 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 8251 shares of Imunon, Inc. ($IMNN) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Imunon, Inc. | $IMNN | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 8251 | $0.00 | 8,251.0000 | 3,070,354 | 9999.99% | 0.27% |
| Aug. 4, 2025 | Imunon, Inc. | $IMNN | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 417 | $0.00 | 417.0000 | 14,620,732 | 9999.99% | 0.00% |
| March 14, 2025 | Imunon, Inc. | $IMNN | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 6250 | $0.00 | 6,250.0000 | 14,620,732 | 9999.99% | 0.04% |
| Oct. 7, 2024 | Imunon, Inc. | $IMNN | Eylward Susan | General Counsel and Corp Sec | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |